Companies Standing to Benefit from the Swine Flu Outbreak | PowerOptions Web Log
We live in an age and environment when, no matter what threat we face, there are organizations that stand to benefit. The current swine flu outbreak (more scientifically known as H1N1) is no exception. Several large international companies are well placed to gain from what is now being referred to as a pandemic. The two essentials in combating this flu will undoubtedly be diagnostics and treatment via antiviral drugs and vaccines. DIAGNOSTICS QIAGEN (QGEN) is a leading provider of sample and assay technologies used to make specific target biomolecules, such as the DNA of a specific virus, visible for subsequent analysis. They have developed more than 500 consumable products and automated solutions which are sold to academic research markets, leading pharmaceutical and biotechnology companies and molecular diagnostics laboratories. QGEN employs more than 2,600 people in over 30 locations worldwide and manufactures universally used assays for influenza screening as well as...
Post to Tumblr